Adalimumab (anti-TNF-alpha)

For research use only. Not for therapeutic Use.

  • Cancer Immunotherapy,
  • CAT Number: M003575
  • CAS Number: 331731-18-1
  • Molecular Formula: C20H22N2O7S
  • Molecular Weight: 434.463
  • Purity: ≥95%
Inquiry Now

Adalimumab (anti-TNF-alpha) is a human IgG1 monoclonal antibody, which binds specifically to tumor necrosis factor α (TNF-α) and blocks its interaction with the p55 and p75 cell surface TNF receptors. By binding to TNFα, ABT-D2E7 reduces the inflammatory response of autoimmune diseases.


Catalog Number M003575
CAS Number 331731-18-1
Synonyms

Adalimumab;D2E7;Humira;Immunoglobulin G1, anti-(human tumor necrosis factor) (human monoclonal D2E7 heavy chain), disulfide with human monoclonal D2E7 light chain, dimer;Unii-fys6T7F842

Molecular Formula C20H22N2O7S
Purity ≥95%
Storage Store at -20°C

Request a Quote